CCL2 and cardiovascular disorder: Although pharmacologic targets for the CCL2-CCR2 axis in pre-clinical model of cardiovascular disease have been highly effective, clinical outcomes based on the CCL2-CCR2 axis for the treatment of cardiovascular disease have been disappointing to date (Table 3).